Biological
Rabies virus strain PM-1503-3M antigen (propiolactone inactivated) clinical trials
Also written Imovax.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2008
How studies write it
Studies that test it under each name
Brand
Studies by the year they started
4 studies that test it; most in 2008 (1)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2016 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 3
- Phase 4
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 1
Synermore Biologics Co., Ltd. (1) · Fidec Corporation (1) · Sanofi Pasteur, a Sanofi Company (1) · Crucell Holland BV (1)
Often tested with
Tested in the same studies.
SYN023 (1) · Rabies virus strain flury LEP antigen (propiolactone inactivated) (1) · Poliovirus Vaccine, Oral (1) · Poliovirus Vaccine, Inactivated (1) · CL184 (1) · Rabies Vaccines (1)
Studies
Open first, then newest update. How each study uses rabies virus strain PM-1503-3M antigen (propiolactone inactivated) is read from its arms, and is right about nine times in ten.
Testing it · 4
- A Comparison of the Safety, PD and PK of a Single Dose of SYN023 Administered With Licensed Rabies VaccinesCompletedPhase 1/2Synermore Biologics Co., Ltd.NCT02956746Written as Imovax
- Safety and Immunogenicity of 1 or 2 Doses of IPV in Latin American Infants Primed With Bivalent OPV VaccineCompletedPhase 4Fidec CorporationNCT01831050Written as Sanofi-Pasteur IPV (Sanofi IPV)
- Immunogenicity and Safety of Fractional Doses of IPV Intradermally vs Full Doses IntramuscularlyCompletedPhase 2Sanofi Pasteur, a Sanofi CompanyNCT00604058Written as Inactivated Poliomyelitis vaccine (IMOVAX)
- Rabies Virus Neutralizing Activity and Safety of CL184, a Monoclonal Antibody Cocktail, in Simulated Rabies Post-Exposure Prophylaxis in Healthy AdultsCompletedPhase 2Crucell Holland BVNCT01228383Written as Human diploid cell vaccine (HDCV)
Given in every arm · 2 — rabies virus strain PM-1503-3M antigen (propiolactone inactivated) is usual care beside what is tested
As the comparator · 1 — what is tested is compared with rabies virus strain PM-1503-3M antigen (propiolactone inactivated)
Codes
What other systems call rabies virus strain PM-1503-3M antigen (propiolactone inactivated) · ClinicalTrials.gg INT016176
- UNII (FDA) C4HQF74XMWRABIES VIRUS STRAIN PM-1503-3M ANTIGEN (PROPIOLACTONE INACTIVATED)One source FDA
- NCI Thesaurus C75813Rabies Virus Strain PM-1503-3M Antigen (Propiolactone Inactivated)One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | C4HQF74XMW | RABIES VIRUS STRAIN PM-1503-3M ANTIGEN (PROPIOLACTONE INACTIVATED) | One source FDA |
| NCI Thesaurus | C75813 | Rabies Virus Strain PM-1503-3M Antigen (Propiolactone Inactivated) | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.